GNH USA

Europe — EMA

Lamivudine/Zidovudine Arrow (Zidovudine, Lamivudine)

GNH USA supplies Lamivudine/Zidovudine Arrow (Lamivudine/Zidovudine), a nucleoside reverse transcriptase inhibitor for HIV-1 infection.

Zidovudine, Lamivudine

Request sourcing

1
Pack/s

What is Zidovudine, Lamivudine?

Lamivudine and Zidovudine, the active ingredients in Lamivudine/Zidovudine Arrow, are nucleoside reverse transcriptase inhibitors presented as an oral tablet for the treatment of HIV‑1 infection in adults and children. The combination blocks viral replication, helping to restore immune function and reduce disease progression.

GNH USA supplies Lamivudine/Zidovudine Arrow as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product meets European Union quality standards and is available for bulk and individual dispensing.

What is Zidovudine, Lamivudine used for?

Lamivudine/Zidovudine is used in antiretroviral therapy targeting HIV‑1 replication.

- HIV‑1 infection (adults): reduces plasma viral load and helps restore CD4+ T‑cell counts. - HIV‑1 infection (children): improves virologic control and supports immune recovery. - Prevention of mother‑to‑child transmission of HIV: used as part of a regimen to lower transmission risk.

What are the side effects of Zidovudine, Lamivudine?

Adverse reactions may occur with Lamivudine/Zidovudine therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Headache: transient cranial discomfort. - Fatigue: general tiredness or weakness. - Anemia: reduction in hemoglobin levels. - Neutropenia: lowered neutrophil count. - Diarrhea: loose stools, often self‑limiting.

Serious or Rare Side Effects: - Lactic acidosis: severe metabolic disturbance requiring urgent care. - Hepatic steatosis: fatty liver disease that can progress to failure. - Bone marrow suppression: pancytopenia or severe anemia. - Hypersensitivity reactions: rash, fever, or organ involvement. - Pancreatitis: inflammation of the pancreas with abdominal pain. - Severe anemia: requiring transfusion or medical intervention.

What precautions apply to Zidovudine, Lamivudine?

Use of Lamivudine/Zidovudine requires careful clinical monitoring.

- Assess renal function: adjust therapy in patients with impaired kidney function. - Monitor hematologic parameters: watch for anemia and neutropenia during treatment. - Screen for hepatitis B infection: risk of reactivation exists. - Avoid in patients with known hypersensitivity to nucleoside reverse transcriptase inhibitors. - Pregnancy considerations: weigh maternal benefits against potential fetal risks. - Store at ambient temperature: keep below 25°C, protect from moisture and light in the original packaging.

What does Zidovudine, Lamivudine interact with?

Lamivudine/Zidovudine may interact with several concomitant medicines.

Major Interactions (Avoid): - Didanosine: increased risk of peripheral neuropathy. - Stavudine: additive mitochondrial toxicity. - Alcohol: heightened potential for liver toxicity.

Moderate Interactions (Monitor Closely): - Protease inhibitors: may raise zidovudine plasma concentrations. - Non‑nucleoside reverse transcriptase inhibitors (efavirenz, nevirapine): can affect lamivudine levels. - Warfarin: possible alteration of INR requiring closer monitoring.

Frequently asked questions

What is Lamivudine/Zidovudine Arrow used for?+
Lamivudine/Zidovudine Arrow is an antiretroviral medication indicated for the treatment of HIV‑1 infection in adults and children. It is also employed as part of combination therapy to reduce the risk of mother‑to‑child transmission of HIV during pregnancy and delivery.
How does Lamivudine/Zidovudine work?+
Both lamivudine and zidovudine are nucleoside reverse transcriptase inhibitors. After oral absorption they are converted inside cells to active triphosphate forms that compete with natural nucleotides, blocking HIV reverse transcriptase and preventing synthesis of viral DNA, which stops viral replication.
What is the usual dose of Lamivudine/Zidovudine?+
The dosing regimen for Lamivudine/Zidovudine is individualized and must be determined by a qualified prescriber based on the patient’s age, weight, renal function, and overall treatment plan. Patients should follow the exact instructions provided by their healthcare professional.
Is Lamivudine/Zidovudine safe in pregnancy or breastfeeding?+
Data on the use of lamivudine/zidovudine during pregnancy are limited, and the drug should only be used when the potential benefit to the mother outweighs any possible risk to the fetus. Breastfeeding decisions should be made in consultation with a physician, considering the infant’s exposure risk.
How do I order Lamivudine/Zidovudine Arrow from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Lamivudine/Zidovudine compare with other antiretroviral options?+
Lamivudine/zidovudine is a well‑established NRTI backbone often combined with a protease inhibitor or an integrase inhibitor. Compared with newer combinations such as tenofovir/emtricitabine, it may have a different safety profile, including a higher incidence of anemia, but remains effective for patients with specific resistance patterns.
What are the storage and handling requirements for Lamivudine/Zidovudine Arrow?+
The product should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Tablets should be kept in a dry place and out of reach of children.
How is Lamivudine/Zidovudine administered?+
Lamivudine/Zidovudine is taken orally, usually as a tablet, with a glass of water. It can be taken with or without food, but patients should follow the prescriber’s guidance regarding timing relative to meals for optimal absorption.
What are the most serious risks associated with Lamivudine/Zidovudine?+
Serious adverse events include severe anemia, lactic acidosis, hepatic steatosis, and bone‑marrow suppression. Patients should be monitored regularly for hematologic changes, liver function abnormalities, and signs of metabolic disturbances, and should seek immediate medical attention if severe symptoms develop.
Who should not use Lamivudine/Zidovudine?+
Individuals with known hypersensitivity to lamivudine, zidovudine, or any component of the formulation should avoid this medication. It is also contraindicated in patients with severe bone‑marrow suppression or uncontrolled hepatic disease, and caution is advised in those with significant renal impairment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Zidovudine, Lamivudine
Route
Oral Use
Manufacturer
Arrow Generiques
Origin
EU

Related products

Combivir

Combivir

Zidovudine, Lamivudine

Viiv Healthcare B.V.
EU
Combivir

Combivir

Zidovudine, Lamivudine

Viiv Healthcare B.V.
EU
Combivir

Combivir

Zidovudine, Lamivudine

Viiv Healthcare B.V.
EU
Combivir

Combivir

Zidovudine, Lamivudine

Viiv Healthcare B.V.
EU